Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Chonnam Medical Journal ; : 24-30, 2023.
Artículo en Inglés | WPRIM | ID: wpr-966532

RESUMEN

The outbreak of the COVID-19 infection has led to the rapidity of vaccine usage in recent years. Emerging data indicate that the efficacy of vaccination against COVID-19 was about 95% in the general population, though its impact is impaired in patients with hematologic malignancies. As such, we decided to research the publications in which the authors reported the impacts of COVID-19 vaccination in patients suffering from hematologic malignancies. We concluded that patients with hematologic malignancies have lower responses, antibody titers as well as an impaired humoral response following vaccination, notably in patients with chronic lymphocytic leukemia (CLL) and lymphoma. Furthermore, it seems that the status of treatment can significantly affect the responses to the COVID-19 vaccination.

2.
Archives of Medical Laboratory Sciences. 2016; 2 (1): 12-18
en Inglés | IMEMR | ID: emr-187157

RESUMEN

Background: Urtica dioica is one of the medicinal herbs with many uses in treating various diseases. In some studies, its antiproliferative and apoptotic effects on cancer cell lines have been shown. Therefore, the evaluation of U. dioica effect was performed on KG-1 cell line for acute myelogenous leukemia [AML] for the first time in this study


Materials and Methods: KG-1 cell line was treated by various extracts [aqueous, hydroalcoholic, chloroform and ethyl acetate] of U. dioica aerial parts and roots in different concentrations. Metabolic activity of extracts on cell line was assessed by MTT assay. To evaluate the percentage of apoptotic cells, the flow cytometry was performed by FITC Annexin V-PI apoptosis detection kit in KG-1 cell line treated with root chloroform [UDC-R] and ethyl acetate [UDE-R] extracts. The results have been reported as percentage of cell viability and IC50


Results: Based on MTT results, the strongest IC50 in KG-1 cell line [219.361microg/ml] was related to UDC-R. The flow cytometric analysis showed that UDC-R and UDE-R in IC50 concentration induced early [53.6% and 57.4%, respectively] and late [27% and 33.2%, respectively] apoptosis in KG-1 cells after 24 hrs. The inhibition of cell proliferation by various extracts of U. dioica was dependent on concentration [p=0.000]


Conclusion: Flow cytometric analysis confirmed that UDC-R and UDE-R extracts affect on proliferation reduction of KG-1 cells by activating the apoptotic pathway

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA